SHOT vs. UG, TOI, LTRN, VHAQ, TSBX, PDEX, PTWO, FHLT, ALRN, and NVNO
Should you be buying Safety Shot stock or one of its competitors? The main competitors of Safety Shot include United-Guardian (UG), Oncology Institute (TOI), Lantern Pharma (LTRN), Viveon Health Acquisition (VHAQ), Turnstone Biologics (TSBX), Pro-Dex (PDEX), Pono Capital Two (PTWO), Future Health ESG (FHLT), Aileron Therapeutics (ALRN), and enVVeno Medical (NVNO). These companies are all part of the "medical" sector.
United-Guardian (NASDAQ:UG) and Safety Shot (NASDAQ:SHOT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.
United-Guardian has a net margin of 23.77% compared to United-Guardian's net margin of -367.77%. Safety Shot's return on equity of 25.18% beat United-Guardian's return on equity.
In the previous week, Safety Shot had 25 more articles in the media than United-Guardian. MarketBeat recorded 26 mentions for Safety Shot and 1 mentions for United-Guardian. Safety Shot's average media sentiment score of 0.72 beat United-Guardian's score of -0.18 indicating that United-Guardian is being referred to more favorably in the media.
United-Guardian received 180 more outperform votes than Safety Shot when rated by MarketBeat users.
United-Guardian has higher revenue and earnings than Safety Shot. Safety Shot is trading at a lower price-to-earnings ratio than United-Guardian, indicating that it is currently the more affordable of the two stocks.
23.2% of United-Guardian shares are owned by institutional investors. Comparatively, 12.6% of Safety Shot shares are owned by institutional investors. 29.0% of United-Guardian shares are owned by insiders. Comparatively, 23.1% of Safety Shot shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
United-Guardian has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, Safety Shot has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500.
Summary
United-Guardian beats Safety Shot on 11 of the 14 factors compared between the two stocks.
Get Safety Shot News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SHOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Safety Shot Competitors List
Related Companies and Tools
